The Australian government has announced the introduction of new tariffs on pharmaceutical products alongside a crackdown on gambling regulations. These measures aim to manage rising health sector costs while imposing stricter controls on gambling to mitigate related social harms. The tariff changes are intended to balance the pharmaceutical market economics, potentially affecting medication pricing and accessibility. Concurrently, the gambling crackdown will see regulators enforcing more stringent compliance measures targeting operators, with the goal of protecting consumers and reducing problem gambling. Together, these initiatives highlight the government's integrated approach to addressing public health and social welfare concerns in Australia.